This Valentine’s Day, Pop Bottles Not Pills!

Valentine’s Day is right around the corner, and for many us, we are looking for ways to spice things up in the bedroom. As you head to the store to pick up that sexy outfit, bottle of wine, box of chocolates, or even a card for your significant other, be sure to leave the sex … Continued

New Campaign Warns Women of Harm from Drug FDA Approved in August

FOR IMMEDIATE RELEASE To schedule an interview with Cindy Pearson contact: Sarah Courtney at sarah@wardcirclestrategies.com or 917-913-1994   Feminist Health Advocates Cite Unsafe Sex Drug for Women in Call for Next FDA Commissioner to Resist Political Pressure WASHINGTON, D.C. – As Dr. Robert Califf testifies before the Senate on his nomination for commissioner of the Food and Drug … Continued

Warning of marginal benefits and serious side effects as drug sales begin

FOR IMMEDIATE RELEASE To schedule an interview with Cindy Pearson and Susan Wood: Sarah Courtney at sarah@wardcirclestrategies.com or 917-913-1994   “PASS ON THE PINK PILL – OR PASS OUT!” Health Advocates Issue Emergency Alert on Addyi:  The New Sex Drug for Women WASHINGTON, DC – The consumer advocacy group National Women’s Health Network (NWHN) today issued its first ever … Continued

Consumer Alert — Pass on the Pink Pill Or Pass Out

EMERGENCY WOMEN’S HEALTH ALERT ON ADDYI The New Sex Drug for Women The National Women’s Health Network is warning all women about the health risks of the new “pink pill” – known as flibanserin and branded as Addyi – alleged to boost female libido. Rather than rely on drug company marketing, NWHN recommends that women … Continued

Female Sexual Dysfunction – Top 10 Things to Know about Addyi

Addyi is the first F.D.A. approved drug to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. Whether you’re considering speaking with your clinician about Addyi or just interested in learning more about this new drug, it is important to know the facts. Addyi has only been tested in a small subset of women. The … Continued

The National Women’s Health Network expresses profound disappointment with FDA’s decision to approve controversial sex drug.

FOR IMMEDIATE RELEASE  Contact:   Christina Cherel at ccherel@nwhn.org or (202) 682-2640   WASHINGTON, D.C. – The National Women’s Health Network (the Network) is profoundly disappointed with the U.S. Food and Drug Administration’s (FDA) decision to approve flibanserin, a proposed treatment for female sexual dysfunction, despite inadequate proof of effectiveness and questionable assurances of the drug’s safety. The … Continued

Sexism and the Pink Pill

I’m sure you’ve turned on the television and seen ads marketing drugs for male sexual dysfunction like Viagra. The pharmaceutical industry spends millions marketing these drugs for men, but have yet to come up with a safe and effective drug treatment for women. An article in the March/April issue of The Women’s Health Activist entitled … Continued

A Little Pink Pill? Not Yet!

For the first time ever, a committee of scientific advisors has recommended the FDA approve a libido drug for women. “Female Viagra” could be on pharmacy shelves by early next year if the FDA follows that recommendation. Many women’s health advocates are calling this a victory, saying this little pink pill finally will bring gender … Continued

Female Viagra? A Pro-Sex Feminist Says No

Vivamus elementum semper nisi. Aenean vulputate eleifend tellus. Aenean leo ligula, porttitor eu, consequat vitae, eleifend ac, enim. Aliquam lorem ante, dapibus in, viverra quis, feugiat a, tellus. Phasellus viverra nulla ut metus varius laoreet.